
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cervical Cancer Immunotherapy: Facts and Hopes
Louise Ferrall, Ken Y. Lin, Richard B.S. Roden, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 18, pp. 4953-4973
Open Access | Times Cited: 257
Louise Ferrall, Ken Y. Lin, Richard B.S. Roden, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 18, pp. 4953-4973
Open Access | Times Cited: 257
Showing 1-25 of 257 citing articles:
Immunotherapy: a promising approach for glioma treatment
Feroza Yasinjan, Xing Yang, Huayue Geng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 84
Feroza Yasinjan, Xing Yang, Huayue Geng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 84
Light-Triggered Nanozymes Remodel the Tumor Hypoxic and Immunosuppressive Microenvironment for Ferroptosis-Enhanced Antitumor Immunity
Zhijin Fan, Sicheng Wu, Huaping Deng, et al.
ACS Nano (2024) Vol. 18, Iss. 19, pp. 12261-12275
Closed Access | Times Cited: 47
Zhijin Fan, Sicheng Wu, Huaping Deng, et al.
ACS Nano (2024) Vol. 18, Iss. 19, pp. 12261-12275
Closed Access | Times Cited: 47
Dendritic Cells in Cancer Immunology and Immunotherapy
Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 981-981
Open Access | Times Cited: 44
Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 981-981
Open Access | Times Cited: 44
Decoding the tumor microenvironment and molecular mechanism: unraveling cervical cancer subpopulations and prognostic signatures through scRNA-Seq and bulk RNA-seq analyses
Zhiheng Lin, Xinhan Li, Hengmei Shi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 32
Zhiheng Lin, Xinhan Li, Hengmei Shi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 32
Gas-Amplified Metalloimmunotherapy with Dual Activation of Pyroptosis and the STING Pathway for Remodeling the Immunosuppressive Cervical Cancer Microenvironment
Lin Liu, Huali Lei, Guanghui Hou, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 12830-12844
Closed Access | Times Cited: 27
Lin Liu, Huali Lei, Guanghui Hou, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 12830-12844
Closed Access | Times Cited: 27
Prevalence and distribution of human papillomavirus genotypes among women attending gynecology clinics in northern Henan Province of China
Xiangpeng Wang, Yuan Song, Xiaofei Wei, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 41
Xiangpeng Wang, Yuan Song, Xiaofei Wei, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 41
Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions
Jiatian Ye, Lan Zheng, Yuedong He, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 23
Jiatian Ye, Lan Zheng, Yuedong He, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 23
Peptide‐Driven Proton Sponge Nano‐Assembly for Imaging and Triggering Lysosome‐Regulated Immunogenic Cancer Cell Death
Tengyu He, Jing Wen, Wenjian Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Closed Access | Times Cited: 14
Tengyu He, Jing Wen, Wenjian Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Closed Access | Times Cited: 14
Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer
Huihui Ji, Jianan Zhang, Hejing Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Huihui Ji, Jianan Zhang, Hejing Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
N6‐methyladenosine (m6A) modification in gynecological malignancies
Chunmei Zhang, Ning Liu
Journal of Cellular Physiology (2022) Vol. 237, Iss. 9, pp. 3465-3479
Closed Access | Times Cited: 30
Chunmei Zhang, Ning Liu
Journal of Cellular Physiology (2022) Vol. 237, Iss. 9, pp. 3465-3479
Closed Access | Times Cited: 30
T cell immunotherapy for cervical cancer: challenges and opportunities
Lingfeng Yu, Gong Lanqing, Ziyu Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Lingfeng Yu, Gong Lanqing, Ziyu Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
A Fully Integrated Conformal Wearable Ultrasound Patch for Continuous Sonodynamic Therapy
Faxing Zou, Yong Luo, Wenxuan Zhuang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 8
Faxing Zou, Yong Luo, Wenxuan Zhuang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 8
Comparison of diagnostic accuracy and acceptability of self-sampling devices for human Papillomavirus detection: A systematic review
Gulzhanat Aimagambetova, Kuralay Atageldiyeva, Аizada Marat, et al.
Preventive Medicine Reports (2024) Vol. 38, pp. 102590-102590
Open Access | Times Cited: 7
Gulzhanat Aimagambetova, Kuralay Atageldiyeva, Аizada Marat, et al.
Preventive Medicine Reports (2024) Vol. 38, pp. 102590-102590
Open Access | Times Cited: 7
HECW1 restrains cervical cancer cell growth by promoting DVL1 ubiquitination and downregulating the activation of Wnt/β-catenin signaling
Zhen Xu, Yilin Guo, Lu Wang, et al.
Experimental Cell Research (2024) Vol. 435, Iss. 2, pp. 113949-113949
Closed Access | Times Cited: 7
Zhen Xu, Yilin Guo, Lu Wang, et al.
Experimental Cell Research (2024) Vol. 435, Iss. 2, pp. 113949-113949
Closed Access | Times Cited: 7
Exosome as a crucial communicator between tumor microenvironment and gastric cancer (Review)
Menghui Wang, Hongxin Shu, Xifu Cheng, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 3
Open Access | Times Cited: 6
Menghui Wang, Hongxin Shu, Xifu Cheng, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 3
Open Access | Times Cited: 6
A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer
Lei Lei, Liao Tan, Long Sui
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 26
Lei Lei, Liao Tan, Long Sui
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 26
Immunotherapy in cervical cancer: From the view of scientometric analysis and clinical trials
Xing Yang, Feroza Yasinjan, Yajie Du, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Xing Yang, Feroza Yasinjan, Yajie Du, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
A scientometric analysis and up-to-date review of nano-based drug delivery systems in glioblastoma treatment
Xing Yang, Feroza Yasinjan, Mei Yang, et al.
Nano Today (2023) Vol. 52, pp. 101961-101961
Closed Access | Times Cited: 13
Xing Yang, Feroza Yasinjan, Mei Yang, et al.
Nano Today (2023) Vol. 52, pp. 101961-101961
Closed Access | Times Cited: 13
M2-type tumor-associated macrophages upregulated PD-L1 expression in cervical cancer via the PI3K/AKT pathway
Fan Guo, Weina Kong, Dewei Li, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Fan Guo, Weina Kong, Dewei Li, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct
Andris M. Evans, Mikhail Salnikov, Steven F. Gameiro, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4825-4825
Open Access | Times Cited: 20
Andris M. Evans, Mikhail Salnikov, Steven F. Gameiro, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4825-4825
Open Access | Times Cited: 20
NEK2 inactivates the Hippo pathway to advance the proliferation of cervical cancer cells by cooperating with STRIPAK complexes
Yanru Zhang, Peng‐Sheng Zheng
Cancer Letters (2022) Vol. 549, pp. 215917-215917
Open Access | Times Cited: 20
Yanru Zhang, Peng‐Sheng Zheng
Cancer Letters (2022) Vol. 549, pp. 215917-215917
Open Access | Times Cited: 20
Emerging Therapeutic Strategies of Different Immunotherapy Approaches Combined with PD-1/PD-L1 Blockade in Cervical Cancer
Yanjun Ge, Yuchen Zhang, Kong‐Nan Zhao, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 3055-3070
Open Access | Times Cited: 19
Yanjun Ge, Yuchen Zhang, Kong‐Nan Zhao, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 3055-3070
Open Access | Times Cited: 19
Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer
Li Liu, Jianfeng Zheng, Hongmei Xia, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 12
Li Liu, Jianfeng Zheng, Hongmei Xia, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 12
Implications of viral infections and oncogenesis in uterine cervical carcinoma etiology and pathogenesis
Daming Chu, Tengteng Liu, Yuan Yao
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 12
Daming Chu, Tengteng Liu, Yuan Yao
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 12
Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma
Shitong Lin, Yuanhui Sun, Canhui Cao, et al.
EBioMedicine (2023) Vol. 97, pp. 104846-104846
Open Access | Times Cited: 12
Shitong Lin, Yuanhui Sun, Canhui Cao, et al.
EBioMedicine (2023) Vol. 97, pp. 104846-104846
Open Access | Times Cited: 12